{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/APGE/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T19:00:09.478Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9074,"canonical_name":"Apogee Therapeutics, Inc.","cik":"0001974640","uei":null,"lei":null,"duns":null,"ticker":"APGE"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":65},"count":65,"timeline":[{"ts":"2026-09-14","kind":"sec.filing","form_type":"15-12G","title":"15-12G — Apogee Therapeutics, Inc. — 2026-09-14","url_slug":"/sec/cik-0001974640/15-12g/0001140361-26-036410","accession_number":"0001140361-26-036410","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Apogee Therapeutics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001974640/8-k/0001140361-26-035537","accession_number":"0001140361-26-035537","importance":35},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Apogee Therapeutics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001974640/4/0001140361-26-035610","accession_number":"0001140361-26-035610","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Apogee Therapeutics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001974640/4/0001140361-26-035613","accession_number":"0001140361-26-035613","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"POSASR","title":"POSASR — Apogee Therapeutics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001974640/posasr/0001140361-26-035593","accession_number":"0001140361-26-035593","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Apogee Therapeutics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001974640/s-8-pos/0001140361-26-035586","accession_number":"0001140361-26-035586","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Apogee Therapeutics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001974640/s-8-pos/0001140361-26-035587","accession_number":"0001140361-26-035587","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Apogee Therapeutics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001974640/s-8-pos/0001140361-26-035588","accession_number":"0001140361-26-035588","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Apogee Therapeutics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001974640/s-8-pos/0001140361-26-035589","accession_number":"0001140361-26-035589","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Apogee Therapeutics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001974640/s-8-pos/0001140361-26-035590","accession_number":"0001140361-26-035590","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Apogee Therapeutics, Inc. — 2026-08-11","url_slug":"/sec/cik-0001974640/8-k/0001140361-26-032231","accession_number":"0001140361-26-032231","importance":35},{"ts":"2026-08-10","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Apogee Therapeutics, Inc. — 2026-08-10","url_slug":"/sec/cik-0001974640/10-q/0001193125-26-341289","accession_number":"0001193125-26-341289","importance":45},{"ts":"2026-08-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Apogee Therapeutics, Inc. — 2026-08-10","url_slug":"/sec/cik-0001974640/8-k/0001193125-26-341239","accession_number":"0001193125-26-341239","importance":35},{"ts":"2026-08-07","kind":"sec.filing","form_type":"4","title":"4 — Apogee Therapeutics, Inc. — 2026-08-07","url_slug":"/sec/cik-0001974640/4/0001104659-26-092838","accession_number":"0001104659-26-092838","importance":30},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Fairmount Funds Management LLC","title":"","shares":31838,"price_per_share":17,"usd_value":541246,"security_title":"Common Stock","importance":15.541246},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Fairmount Healthcare Fund II L.P.","title":"","shares":31838,"price_per_share":17,"usd_value":541246,"security_title":"Common Stock","importance":15.541246},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Kiselak Tomas","title":"","shares":31838,"price_per_share":17,"usd_value":541246,"security_title":"Common Stock","importance":15.541246},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Harwin Peter Evan","title":"","shares":31838,"price_per_share":17,"usd_value":541246,"security_title":"Common Stock","importance":15.541246},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Fairmount Funds Management LLC","title":"","shares":10370,"price_per_share":43.85,"usd_value":454725,"security_title":"Common Stock","importance":15.4547245},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Fairmount Healthcare Fund II L.P.","title":"","shares":10370,"price_per_share":43.85,"usd_value":454725,"security_title":"Common Stock","importance":15.4547245},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Kiselak Tomas","title":"","shares":10370,"price_per_share":43.85,"usd_value":454725,"security_title":"Common Stock","importance":15.4547245},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Harwin Peter Evan","title":"","shares":10370,"price_per_share":43.85,"usd_value":454725,"security_title":"Common Stock","importance":15.4547245},{"ts":"2026-08-06","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Apogee Therapeutics, Inc. — 2026-08-06","url_slug":"/sec/cik-0001974640/defa14a/0001140361-26-031499","accession_number":"0001140361-26-031499","importance":30},{"ts":"2026-08-05","kind":"sec.insider.5500","reporter":"Dambkowski Carl","title":"Chief Medical Officer","shares":5500,"price_per_share":134.17,"usd_value":737935,"security_title":"Common Stock","importance":15.737935},{"ts":"2026-08-05","kind":"sec.insider.4125","reporter":"Dambkowski Carl","title":"Chief Medical Officer","shares":4125,"price_per_share":22.86,"usd_value":94298,"security_title":"Common Stock","importance":15.0942975},{"ts":"2026-08-03","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Apogee Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001974640/defa14a/0001140361-26-030996","accession_number":"0001140361-26-030996","importance":30},{"ts":"2026-07-24","kind":"sec.insider.15000","reporter":"Henderson Jane","title":"Chief Financial Officer","shares":15000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-24","kind":"sec.insider.g","reporter":"Henderson Jane","title":"Chief Financial Officer","shares":15000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — Apogee Therapeutics, Inc. — 2026-07-16","url_slug":"/sec/cik-0001974640/4/0001104659-26-084344","accession_number":"0001104659-26-084344","importance":30},{"ts":"2026-07-14","kind":"sec.insider.g","reporter":"Dambkowski Carl","title":"Chief Medical Officer","shares":8000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-13","kind":"sec.filing","form_type":"DEFM14A","title":"DEFM14A — Apogee Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001974640/defm14a/0001140361-26-028341","accession_number":"0001140361-26-028341","importance":30},{"ts":"2026-07-10","kind":"sec.insider.g","reporter":"HENDERSON MICHAEL THOMAS","title":"Chief Executive Officer","shares":75046,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-08","kind":"sec.insider.s","reporter":"HENDERSON MICHAEL THOMAS","title":"Chief Executive Officer","shares":20000,"price_per_share":133.63,"usd_value":2672600,"security_title":"Common Stock","importance":37.6726},{"ts":"2026-07-08","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Apogee Therapeutics, Inc. — 2026-07-08","url_slug":"/sec/cik-0001974640/schedule-13g-a/0000315066-26-001471","accession_number":"0000315066-26-001471","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Apogee Therapeutics, Inc. — 2026-07-08","url_slug":"/sec/cik-0001974640/schedule-13g-a/0000902219-26-000212","accession_number":"0000902219-26-000212","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"PREM14A","title":"PREM14A — Apogee Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001974640/prem14a/0001140361-26-027469","accession_number":"0001140361-26-027469","importance":30},{"ts":"2026-07-01","kind":"sec.form144","reporter":"CARL DAMBKOWSKI","title":"Officer","shares":16500,"usd_value":2190045,"security_title":"Common","approx_sale_date":"2026-07-01","accession_number":"0001950047-26-006771","importance":40.438009},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Dambkowski Carl","title":"Chief Medical Officer","shares":5500,"price_per_share":132.74,"usd_value":730070,"security_title":"Common Stock","importance":35.73007},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Apogee Therapeutics, Inc. — 2026-07-01","url_slug":"/sec/cik-0001974640/144/0001950047-26-006771","accession_number":"0001950047-26-006771","importance":30},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Dambkowski Carl","title":"Chief Medical Officer","shares":4125,"price_per_share":22.86,"usd_value":94298,"security_title":"Common Stock","importance":15.0942975},{"ts":"2026-06-26","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Apogee Therapeutics, Inc. — 2026-06-26","url_slug":"/sec/cik-0001974640/defa14a/0001140361-26-026601","accession_number":"0001140361-26-026601","importance":30},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"HENDERSON MICHAEL THOMAS","title":"Chief Executive Officer","shares":80000,"price_per_share":132.54,"usd_value":10603200,"security_title":"Common Stock","importance":45.6032},{"ts":"2026-06-22","kind":"sec.form144","reporter":"HENDERSON MICHAEL THOMAS","title":"Officer, Director","shares":80000,"usd_value":10603532,"security_title":"COMMON","approx_sale_date":"2026-06-22","accession_number":"0001949846-26-000395","importance":42.1207064},{"ts":"2026-06-22","kind":"sec.form144","reporter":"CARL DAMBKOWSKI","title":"Officer","shares":15400,"usd_value":1391852,"security_title":"Common","approx_sale_date":"2026-06-22","accession_number":"0001950047-26-006388","importance":40.2783704},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Dambkowski Carl","title":"Chief Medical Officer","shares":26400,"price_per_share":132.6,"usd_value":3500640,"security_title":"Common Stock","importance":38.50064},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Apogee Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001974640/8-k/0001140361-26-025841","accession_number":"0001140361-26-025841","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Apogee Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001974640/8-k/0001140361-26-025844","accession_number":"0001140361-26-025844","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"144","title":"144 — Apogee Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001974640/144/0001950047-26-006388","accession_number":"0001950047-26-006388","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Apogee Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001974640/defa14a/0001140361-26-025845","accession_number":"0001140361-26-025845","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Apogee Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001974640/defa14a/0001140361-26-025980","accession_number":"0001140361-26-025980","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — JONES WILLIAM A JR — 2026-06-11","url_slug":"/sec/cik-0001373097/4/0001104659-26-073059","accession_number":"0001104659-26-073059","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — Apogee Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001974640/4/0001104659-26-073056","accession_number":"0001104659-26-073056","importance":30},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"HENDERSON MICHAEL THOMAS","title":"Chief Executive Officer","shares":7654,"price_per_share":82.78,"usd_value":633598,"security_title":"Common Stock","importance":35.63359812},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"HENDERSON MICHAEL THOMAS","title":"Chief Executive Officer","shares":6770,"price_per_share":82.21,"usd_value":556562,"security_title":"Common Stock","importance":35.5565617},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"HENDERSON MICHAEL THOMAS","title":"Chief Executive Officer","shares":2305,"price_per_share":86.27,"usd_value":198852,"security_title":"Common Stock","importance":35.19885235},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"HENDERSON MICHAEL THOMAS","title":"Chief Executive Officer","shares":1577,"price_per_share":85.19,"usd_value":134345,"security_title":"Common Stock","importance":35.13434463},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"HENDERSON MICHAEL THOMAS","title":"Chief Executive Officer","shares":1080,"price_per_share":84.18,"usd_value":90914,"security_title":"Common Stock","importance":35.0909144},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"HENDERSON MICHAEL THOMAS","title":"Chief Executive Officer","shares":614,"price_per_share":86.89,"usd_value":53350,"security_title":"Common Stock","importance":35.05335046},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"Dambkowski Carl","title":"Chief Medical Officer","shares":5500,"price_per_share":78.71,"usd_value":432905,"security_title":"Common Stock","importance":35.432905},{"ts":"2026-06-03","kind":"sec.insider.5500","reporter":"Dambkowski Carl","title":"Chief Medical Officer","shares":5500,"price_per_share":78.71,"usd_value":432905,"security_title":"Common Stock","importance":15.432905},{"ts":"2026-06-03","kind":"sec.insider.4125","reporter":"Dambkowski Carl","title":"Chief Medical Officer","shares":4125,"price_per_share":22.86,"usd_value":94298,"security_title":"Common Stock","importance":15.0942975},{"ts":"2026-06-03","kind":"sec.insider.m","reporter":"Dambkowski Carl","title":"Chief Medical Officer","shares":4125,"price_per_share":22.86,"usd_value":94298,"security_title":"Common Stock","importance":15.0942975},{"ts":"2026-05-13","kind":"sec.form144","reporter":"HENDERSON MICHAEL THOMAS","title":"Officer, Director","shares":60000,"usd_value":4948200,"security_title":"COMMON","approx_sale_date":"2026-05-13","accession_number":"0001949846-26-000273","importance":40.98964},{"ts":"2026-05-13","kind":"sec.insider.s","reporter":"HENDERSON MICHAEL THOMAS","title":"Chief Executive Officer","shares":18659,"price_per_share":82.05,"usd_value":1530971,"security_title":"Common Stock","importance":36.53097095},{"ts":"2026-05-13","kind":"sec.insider.s","reporter":"HENDERSON MICHAEL THOMAS","title":"Chief Executive Officer","shares":1341,"price_per_share":82.58,"usd_value":110740,"security_title":"Common Stock","importance":35.11073978}]}